Advice to warn patients about rare side effects overturns accepted practice

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7071.1554a (Published 14 December 1996) Cite this as: BMJ 1996;313:1554
  1. James Warner
  1. Lecturer in psychiatry Royal Free Hospital School of Medicine, University of London, London NW3 2PF

    EDITOR,—The Committee on Safety of Medicines recently advised doctors in Britain to warn patients who were being prescribed mefloquine about potential neuropsychiatric side effects, which occur with a frequency of around 1 in …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial